PMID: 9539267Apr 16, 1998Paper

Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule

Psychopharmacology
A MendrekA G Phillips

Abstract

Two groups of male rats were tested to determine whether pre-exposure to d-amphetamine would enhance the motivation to self-administer the drug under a progressive ratio schedule of reinforcement. In the first phase of the experiment, one group of rats received d-amphetamine (2 mg/kg IP), while a second group received saline on alternate days for a total of ten injections. Following a 21-day drug withdrawal period, behavioral sensitization was confirmed by a significant increase in amphetamine-induced stereotypy in the d-amphetamine-pretreated group, relative to the saline-pretreated group. In the second phase of the study, all rats were implanted with chronic jugular catheters and trained to self-administer d-amphetamine (0.2 mg/kg per infusion) under a fixed-ratio schedule of reinforcement. The progressive ratio paradigm was then imposed for 7 consecutive days; d-amphetamine-pretreated rats attained significantly higher break points than saline-pretreated animals. These data suggest that pre-exposure to d-amphetamine may enhance the motivation to self-administer this drug.

Citations

Apr 24, 2007·Neurotoxicity Research·Neil E Paterson, Athina Markou
Feb 14, 2007·Psychopharmacology·Jasmine J Yap, Klaus A Miczek
Dec 22, 2007·Psychopharmacology·Herbert E CovingtonKlaus A Miczek
May 27, 2008·Psychopharmacology·Anne Marie BradyPatricio O'Donnell
Mar 17, 2004·Neuroscience and Biobehavioral Reviews·Drake Morgan, David C S Roberts
Dec 4, 2003·Pharmacology, Biochemistry, and Behavior·Fay A Guarraci, Ann S Clark
Sep 6, 2000·Pharmacology, Biochemistry, and Behavior·S Schenk, B Partridge
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·A R CaggiulaA F Sved
Jun 14, 2002·Pharmacology, Biochemistry, and Behavior·Andrew D MorganMarilyn E Carroll
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
Jan 20, 2006·Behavioral Neuroscience·Leora Yetnikoff, Andreas Arvanitogiannis
Sep 22, 2005·Experimental and Clinical Psychopharmacology·Frances K McSweeneyBenjamin P Kowal
May 28, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Drake MorganDavid C S Roberts
Jun 24, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiang-Yang Zhang, Therese A Kosten
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Patricia Di Ciano
Aug 24, 1999·The European Journal of Neuroscience·V DerocheP V Piazza
Nov 10, 2000·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·K A PerkinsA R Caggiula
May 1, 2002·Behavioural Pharmacology·G Brown, D N Stephens
Sep 3, 2004·Behavioural Pharmacology·A Badiani, T E Robinson
Jul 23, 1999·Annals of the New York Academy of Sciences·D S LorrainP Vezina
Apr 15, 2011·Pharmacological Reviews·Jeffery D Steketee, Peter W Kalivas
Aug 20, 2002·Annual Review of Psychology·Terry E Robinson, Kent C Berridge
Jul 5, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xiaoting WangMarina E Wolf
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jane R TaylorJames A Bibb
Nov 26, 2013·Pharmacology, Biochemistry, and Behavior·Fay A Guarraci, Jessica L Bolton
Jun 28, 2015·Neuroscience and Biobehavioral Reviews·Florence AllainAnne-Noël Samaha

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.